[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366277-105":59,"doc-detail-366277-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immuno-informatics-analyses-of-important-esophageal-cancer-associated-viruses-for-multi-epitope-vaccine-design","Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design","","Immuno-informatics analyses address the high lethality and poor prognosis of esophageal cancer by targeting oncogenic viruses linked to the disease. Protein sequences from ten viral candidates were screened for antigenicity and five highly antigenic proteins were selected across HCMV, HPV, HHV-8, HIV, and EBV. Predicted CTL, HTL, and B-cell epitopes were evaluated for immunogenicity, allergenicity, and toxicity. The final multi-epitope vaccine with defensin adjuvant showed antigenic, non-allergenic, nontoxic properties, with strong TLR3 docking and stable molecular dynamics results, and in silico cloning supported expression potential in E. coli.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immuno-informatics-analyses-of-important-esophageal-cancer-associated-viruses-for-multi-epitope-vaccine-design/366277/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immuno-informatics-analyses-of-important-esophageal-cancer-associated-viruses-for-multi-epitope-vaccine-design/366277.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study?","Question",{"text":112,"@type":113},"To design a multi-epitope vaccine against viral agents associated with esophageal cancer using immuno-informatics and bioinformatics approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were viral candidates and epitopes selected?",{"text":117,"@type":113},"Ten viral protein sequences were retrieved and assessed for antigenicity, followed by prediction and screening of CTL, HTL, and B-cell epitopes for immunogenicity, allergenicity, and toxicity.",{"name":119,"@type":110,"acceptedAnswer":120},"What validation steps supported the vaccine design?",{"text":121,"@type":113},"Molecular docking and molecular dynamics simulations evaluated binding between the vaccine and TLR3, and codon optimization with in silico cloning assessed expression potential in E. coli.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366277,1790528071,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Original Research PUBLISHED 08 July 2025  \nDOI 10.3389/fimmu.2025.1587224  \nOPEN ACCESS  \nEDITED BY  \nMohamed Rahouma,  \nNewYork-Presbyterian, United States  \nREVIEWED BY  \nPrasanna Srinivasan Ramalingam, Vellore Institute of Technology, India Subrat Kumar Swain,  \nSiksha O Anusandhan University, India  \n*CORRESPONDENCE  \nZafer Saad Al Shehri  \n [zaf@su.edu.sa](zaf@su.edu.sa)  \nRECEIVED 05 March 2025  \nACCEPTED 14 June 2025  \nPUBLISHED 08 July 2025  \nCITATION  \nShehri ZSA (2025) Immuno-informatics  \nanalyses of important esophageal cancer associated viruses for multi-epitope vaccine design.  \nFront. Immunol. 16:1587224 .  \ndoi: 10.3389/fimmu.2025.1587224  \nCOPYRIGHT  \n© 2025 Shehri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nImmuno-informatics analyses of important esophageal cancer associated viruses for multi epitope vaccine design  \nZafer Saad Al Shehri*  \nDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Dawadmi, Saudi Arabia  \nIntroduction: Esophageal cancer (EC) is a highly lethal malignancy characterized by the uncontrolled proliferation of cancerous cells within the esophagus. Despite recent advancements in therapeutic strategies, the prognosis remains poor, underscoring the urgent need for novel preventive and therapeutic approaches. Notably, several oncogenic viruses have been implicated in EC pathogenesis, prompting the exploration of epitope-based vaccines through immunoinformatics.  \nMethods: Using immunoinformatics and bioinformatics approaches, we designed a novel multi-epitope vaccine targeting viral agents associated with EC. Protein sequences of ten viral candidates were retrieved from the UniProt database and evaluated for antigenicity using the VaxiJen server. Five highly antigenic proteins derived from Human Cytomegalovirus (HCMV), Human Papillomavirus (HPV), Human Herpesvirus 8 (HHV-8), Human Immunodeﬁciency Virus (HIV), and Epstein–Barr Virus (EBV) were selected. T cell (CTL and HTL) and B cell (LBL) epitopes were predicted and screened for immunogenicity, allergenicity, and toxicity. The ﬁnal vaccine construct incorporated b-defensin as an adjuvant and included 3 HTL, 8 CTL, and 8 LBL epitopes. Molecular docking and molecular dynamics (MD) simulations were conducted to assess the binding afﬁnity of the vaccine with Toll-like receptor 3 (TLR3) . In silico cloning was also performed using the pET-28a(+) vector in Escherichia coli strain K12 .  \nResults: The designed vaccine was found to be antigenic, non-allergenic, and nontoxic. Molecular docking revealed strong binding afﬁnity between the vaccine construct and TLR3, which was further supported by MD simulation results indicating stable complex formation. Codon optimization and in silico cloning conﬁrmed the high expression potential of the vaccine in the E. coli expression system.  \nDiscussion: The in silico analyses suggest that the developed multi-epitope vaccine construct is a promising candidate for preventing EC associated with viral infections. While these ﬁndings are encouraging, further experimental validation through in vitro and in vivo studies is essential to conﬁrm the vaccine's safety, immunogenicity, and protective efﬁcacy.  \nKEYWORDS  \nesophageal cancer, Epstein-Barr virus (EBV), human papillomavirus (HPV), human cytomegalovirus (hcmv), molecular docking simulation, multi-epitope vaccine  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nEsophageal cancer (EC) is a cancer that begins in the esophagus, the tube that connects the throat and stomach. It typically","cbCainK9Za6JCSEx","https://ap.wps.com/l/cbCainK9Za6JCSEx","pdf",14622068,17,"English","# Introduction\n## Methods\n## Results\n## Discussion\n## Keywords","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To design a multi-epitope vaccine against viral agents associated with esophageal cancer using immuno-informatics and bioinformatics approaches.\"},{\"question\":\"How were viral candidates and epitopes selected?\",\"answer\":\"Ten viral protein sequences were retrieved and assessed for antigenicity, followed by prediction and screening of CTL, HTL, and B-cell epitopes for immunogenicity, allergenicity, and toxicity.\"},{\"question\":\"What validation steps supported the vaccine design?\",\"answer\":\"Molecular docking and molecular dynamics simulations evaluated binding between the vaccine and TLR3, and codon optimization with in silico cloning assessed expression potential in E. coli.\"}]","Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design | PDF",1790164549,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/144343f29b1f653232f828a573bf056a.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3329038607916c6becb3178df8ae4fa7.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20ae78d26b7debe42af206ad378c7db7.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f16e885566b89753248eb23de567649e.webp",980,1385]